Quick Takeaways
- TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD has 37 insiders with reported activity on this page.
- Net insider value flow over the last year: -$92,649,342.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 37 Insiders of TEVA PHARMACEUTICAL INDUSTRIES LTD
- Symbol
- TEVA on NYSE, TEVJF on OTC
- Location
- Tel Aviv
What Changed
- Buy value: $20,988; sell value: $92,670,329.
- Net share flow: -3,141,067.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$92,649,342.
Buys
$20,988
Shares: 1,113
Insiders: 1
Sells
$92,670,330
Shares: 3,142,180
Insiders: 11
Net
-$92,649,342
Shares: -3,141,067
Insiders: -10
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 1,940,900 | $0 | $64,492,925 | -$64,492,925 |
| 3-6 | 0 | 530,289 | $0 | $15,008,379 | -$15,008,379 |
| 6-9 | 1,113 | 212,300 | $20,988 | $5,122,444 | -$5,101,456 |
| 9-12 | 0 | 458,691 | $0 | $8,046,582 | -$8,046,582 |
TEVA PHARMACEUTICAL INDUSTRIES LTD executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Richard D. Francis | President and CEO | $37,072,264 | -$31,051,733 | -46% | Filing P/S | 05 Mar 2026 |
| Amir Elstein | Director | $35,810,081 | Mixed | 05 Jun 2025 | ||
| Kare Schultz | President and CEO, Director | $15,013,641 | Mixed | 01 Nov 2022 | ||
| Roberto A. Mignone | Director | $13,888,444 | -$8,464,031 | -38% | Mixed | 16 Dec 2025 |
| Eliyahu Sharon Kalif | EVP, Chief Financial Officer | $11,325,138 | -$12,587,172 | -53% | Mixed | 05 Mar 2026 |
| Sol J. Barer | Director | $7,255,277 | Mixed | 05 Jun 2025 | ||
| Eric A. Hughes | Executive Vice President, Global R&D and Chief Medical Officer | $3,411,035 | -$4,080,884 | -54% | Filing P/S | 05 Mar 2026 |
| Mark Sabag | Executive Vice President, International Markets Commercial | $2,825,937 | -$13,147,688 | -82% | Filing P/S | 01 May 2026 |
| Christine Fox | EVP, U.S. Commercial | $2,247,375 | -$2,749,766 | -55% | Filing P/S | 30 Apr 2026 |
| Richard Daniell | EVP, Europe Commercial | $1,973,727 | -$12,078,289 | -86% | Filing P/S | 05 May 2026 |
| Eric Drape | Executive VP Global Operations | $1,972,100 | Mixed | 05 Mar 2024 | ||
| Gerald M. Lieberman | Director | $1,968,517 | Mixed | 05 Jun 2025 | ||
| Rosemary A. Crane | Director | $1,927,498 | Mixed | 05 Jun 2025 | ||
| Perry D. Nisen | Director | $1,792,493 | Mixed | 05 Jun 2025 | ||
| Ronit Satchi-Fainaro | Director | $1,666,441 | Mixed | 05 Jun 2025 | ||
| Sven Dethlefs | EVP, North America Commercial | $1,609,736 | Mixed | 06 Mar 2023 | ||
| Dov Bergwerk | Acting Chief Legal Officer | $1,272,029 | Mixed | 28 Feb 2024 | ||
| Janet S. Vergis | Director | $1,254,345 | Mixed | 05 Jun 2025 | ||
| Tal Zvi Zaks | Director | $1,000,317 | Mixed | 05 Jun 2025 | ||
| Amir Weiss | Chief Accounting Officer | $720,576 | -$1,056,512 | -59% | Filing P/S | 06 May 2026 |
| Eli Shani | EVP,Global Marketing&Portfolio | $527,828 | Mixed | 03 Mar 2023 | ||
| Galia Inbar | EVP, Chief Human Resources Officer and Corporate Affairs | $447,848 | Mixed | 03 Mar 2023 | ||
| Varda Shalev | Director | $383,025 | Mixed | 05 Jun 2025 | ||
| Brian P. Savage | Interim Chief Legal Officer | $345,628 | -$163,759 | -32% | Filing P/S | 05 Mar 2026 |
| Matthew Shields | EVP, Global Operations | $316,335 | -$653,333 | -67% | Filing P/S | 05 Mar 2026 |
| David R. McAvoy | EVP, Chief Legal Officer | $245,652 | +$20,988 | +9.3% | Filing P/S | 05 Sep 2025 |
| Placid Jover | Executive Vice President, Chief Human Resources Officer | $214,521 | -$539,856 | -72% | Filing P/S | 05 Mar 2026 |
| Angus Grant | EVP, Business Development | $152,893 | Filing P/S | 09 Aug 2024 | ||
| Chen Lichtenstein | Director | $120,724 | Mixed | 02 Dec 2025 | ||
| David M. Stark | Exec. VP Chief Legal Officer | $28,951 | Mixed | 06 Mar 2023 | ||
| Hafrun Fridriksdottir | Executive VP, Global R&D | $13,496 | Mixed | 17 May 2022 | ||
| Vikki L. Conway | Acting Head of Global Human Resources | $0 | Mixed | 13 May 2024 | ||
| Jean Michel Halfon | Director | Mixed | 04 Aug 2022 | |||
| Evan Lippman | EVP, Business Development | Mixed | 04 Mar 2026 | |||
| Andrew Weil | Chief Accounting Officer | Mixed | 02 Nov 2021 | |||
| Abbas Hussain | Director | Mixed | 14 Jun 2021 | |||
| Nechemia Jacob Peres | Director | Mixed | 04 Aug 2022 |
Top shareholders of TEVA PHARMACEUTICAL INDUSTRIES LTD (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Migdal Insurance & Financial Holdings Ltd. |
13D/G
13F
|
Company |
5.4%
|
61,689,363
|
$2,022,794,213 | $0 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5.1%
|
58,302,688
|
$1,819,626,890 | — | 31 Dec 2025 | |
| Harel Insurance Investments & Financial Services Ltd. |
13F
13D/G
|
Company |
6.3%
from 13D/G
|
44,951,773
|
$1,402,945,000 | — | 31 Dec 2025 | |
| Phoenix Financial Ltd. |
13F
13D/G
|
Company |
5%
from 13D/G
|
41,087,131
|
$1,282,329,359 | — | 31 Dec 2025 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
13D/G
|
Company |
5%
from 13D/G
|
39,316,183
|
$1,227,058,071 | — | 31 Dec 2025 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
3.3%
|
37,404,106
|
$1,171,378,000 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
3.1%
|
35,182,949
|
$1,098,059,838 | — | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
2.1%
from 13D/G
|
29,014,982
|
$905,557,612 | — | 31 Dec 2025 | |
| Lingotto Investment Management LLP |
13F
|
Company |
2.5%
|
28,422,768
|
$887,074,589 | — | 31 Dec 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
1.9%
|
21,355,510
|
$666,505,467 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
17,348,809
|
$541,456,329 | — | 31 Dec 2025 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
16,720,209
|
$521,837,723 | — | 31 Dec 2025 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
14,007,078
|
$438,981,825 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
10,326,504
|
$320,294,514 | — | 31 Dec 2025 | |
| Altshuler Shaham Ltd |
13F
|
Company |
0.74%
|
8,494,121
|
$268,669,846 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.74%
|
8,444,801
|
$263,562,311 | — | 31 Dec 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.65%
|
7,426,885
|
$231,793,081 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.59%
|
6,785,729
|
$211,782,601 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.56%
|
6,412,808
|
$200,143,728 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.51%
|
5,878,067
|
$183,454,485 | — | 31 Dec 2025 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.51%
|
5,874,870
|
$183,355,000 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
5,599,996
|
$174,775,876 | — | 31 Dec 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.43%
|
4,987,690
|
$155,665,805 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.41%
|
4,743,777
|
$148,053,722 | — | 31 Dec 2025 | |
| SOUND SHORE MANAGEMENT INC /CT/ |
13F
|
Company |
0.38%
|
4,309,906
|
$134,512,166 | — | 31 Dec 2025 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.37%
|
4,280,425
|
$133,592,000 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.37%
|
4,277,986
|
$133,515,930 | — | 31 Dec 2025 | |
| ION Fund Management Ltd |
13F
|
Company |
0.35%
|
4,050,000
|
$126,400,500 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.33%
|
3,847,855
|
$120,091,555 | — | 31 Dec 2025 | |
| AustralianSuper Pty Ltd |
13F
|
Company |
0.33%
|
3,841,151
|
$119,882,323 | — | 31 Dec 2025 | |
| PointState Capital LP |
13F
|
Company |
0.33%
|
3,793,986
|
$118,410,303 | — | 31 Dec 2025 | |
| TODD ASSET MANAGEMENT LLC |
13F
|
Company |
0.33%
|
3,777,137
|
$117,884,625 | — | 31 Dec 2025 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0.32%
|
3,718,454
|
$116,052,949 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.31%
|
3,608,387
|
$112,617,759 | — | 31 Dec 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.31%
|
3,535,962
|
$110,357,374 | — | 31 Dec 2025 | |
| National Pension Service |
13F
|
Company |
0.3%
|
3,500,558
|
$109,252,415 | — | 31 Dec 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.3%
|
3,449,607
|
$107,662,000 | — | 31 Dec 2025 | |
| Swiss National Bank |
13F
|
Company |
0.29%
|
3,286,200
|
$102,562,302 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.28%
|
3,229,126
|
$100,781,022 | — | 31 Dec 2025 | |
| FIL Ltd |
13F
|
Company |
0.28%
|
3,166,248
|
$98,818,600 | — | 31 Dec 2025 | |
| DME Capital Management, LP |
13F
|
Company |
0.27%
|
3,058,734
|
$95,463,088 | — | 31 Dec 2025 | |
| Parsifal Capital Management, LP |
13F
|
Company |
0.25%
|
2,819,933
|
$88,010,109 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
0.24%
|
2,794,784
|
$87,225,210 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.24%
|
2,791,184
|
$87,115,810 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.24%
|
2,722,784
|
$84,978,089 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.24%
|
2,710,105
|
$84,582,379 | — | 31 Dec 2025 | |
| Castle Hook Partners LP |
13F
|
Company |
0.23%
|
2,627,792
|
$82,013,389 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.22%
|
2,511,656
|
$78,388,784 | — | 31 Dec 2025 | |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY |
13F
|
Company |
0.21%
|
2,445,300
|
$76,317,000 | — | 31 Dec 2025 | |
| Capital World Investors |
13F
|
Company |
0.21%
|
2,361,012
|
$73,687,195 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for TEVA PHARMACEUTICAL INDUSTRIES LTD
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Amir Weiss | TEVA | Ordinary Shares | Sale | -34.8% | $384,444 | $36.00 | -10,679 | 20,016 | 06 May 2026 | Direct |
| Richard Daniell | TEVA | Ordinary Shares | Sale | -35% | $1,062,000 | $35.40 | -30,000 | 55,755 | 05 May 2026 | Direct |
| Mark Sabag | TEVA | Ordinary Shares | Sale | -64.1% | $5,045,118 | $34.99 | -144,180 | 80,760 | 01 May 2026 | Direct |
| Christine Fox | TEVA | Ordinary Shares | Sale | -25% | $750,620 | $35.31 | -21,258 | 63,647 | 30 Apr 2026 | Direct |
| Mark Sabag | TEVA | Ordinary Shares | Sale | -21.6% | $1,871,816 | $30.14 | -62,102 | 224,940 | 17 Mar 2026 | Direct |
| Mark Sabag | TEVA | Ordinary Shares | Options Exercise | 5.8% | 15,723 | 287,042 | 05 Mar 2026 | Direct | ||
| Mark Sabag | TEVA | Restricted Share Units | Options Exercise | -25% | -15,723 | 47,170 | 05 Mar 2026 | Direct | ||
| Eliyahu Sharon Kalif | TEVA | Ordinary Shares | Options Exercise | 6.52% | 19,916 | 325,435 | 05 Mar 2026 | Direct | ||
| Eliyahu Sharon Kalif | TEVA | Restricted Share Units | Options Exercise | -25% | -19,916 | 59,748 | 05 Mar 2026 | Direct | ||
| Amir Weiss | TEVA | Ordinary Shares | Options Exercise | 13% | 3,537 | 30,695 | 05 Mar 2026 | Direct | ||
| Amir Weiss | TEVA | Restricted Share Units | Options Exercise | -25% | -3,537 | 10,613 | 05 Mar 2026 | Direct | ||
| Richard D. Francis | TEVA | Ordinary Shares | Sale | -1.68% | $634,160 | $31.67 | -20,025 | 1,170,639 | 05 Mar 2026 | Direct |
| Richard D. Francis | TEVA | Ordinary Shares | Options Exercise | 3.7% | 42,452 | 1,190,664 | 05 Mar 2026 | Direct | ||
| Richard D. Francis | TEVA | Restricted Share Units | Options Exercise | -25% | -42,452 | 127,359 | 05 Mar 2026 | Direct | ||
| Christine Fox | TEVA | Ordinary Shares | Sale | -8.54% | $250,940 | $31.67 | -7,924 | 84,905 | 05 Mar 2026 | Direct |
| Christine Fox | TEVA | Ordinary Shares | Options Exercise | 23.8% | 17,819 | 92,829 | 05 Mar 2026 | Direct | ||
| Christine Fox | TEVA | Restricted Share Units | Options Exercise | -25% | -17,819 | 53,459 | 05 Mar 2026 | Direct | ||
| Eric A. Hughes | TEVA | Ordinary Shares | Sale | -8.13% | $301,895 | $31.67 | -9,533 | 107,711 | 05 Mar 2026 | Direct |
| Eric A. Hughes | TEVA | Ordinary Shares | Options Exercise | 20.1% | 19,654 | 117,244 | 05 Mar 2026 | Direct | ||
| Eric A. Hughes | TEVA | Restricted Share Units | Options Exercise | -25% | -19,654 | 58,962 | 05 Mar 2026 | Direct | ||
| Richard Daniell | TEVA | Ordinary Shares | Sale | -16.8% | $547,705 | $31.67 | -17,295 | 85,755 | 05 Mar 2026 | Direct |
| Richard Daniell | TEVA | Ordinary Shares | Options Exercise | 20.2% | 17,295 | 103,050 | 05 Mar 2026 | Direct | ||
| Richard Daniell | TEVA | Restricted Share Units | Options Exercise | -25% | -17,295 | 51,887 | 05 Mar 2026 | Direct | ||
| Placid Jover | TEVA | Ordinary Shares | Sale | -67.6% | $448,108 | $31.67 | -14,150 | 6,774 | 05 Mar 2026 | Direct |
| Placid Jover | TEVA | Ordinary Shares | Options Exercise | 208.9% | 14,150 | 20,924 | 05 Mar 2026 | Direct | ||
| Placid Jover | TEVA | Restricted Share Units | Options Exercise | -25% | -14,150 | 42,453 | 05 Mar 2026 | Direct | ||
| Brian P. Savage | TEVA | Ordinary Shares | Sale | -9.36% | $35,690 | $31.67 | -1,127 | 10,914 | 05 Mar 2026 | Direct |
| Brian P. Savage | TEVA | Ordinary Shares | Options Exercise | 42.3% | 3,580 | 12,041 | 05 Mar 2026 | Direct | ||
| Brian P. Savage | TEVA | Restricted Share Units | Options Exercise | -25% | -3,580 | 10,740 | 05 Mar 2026 | Direct | ||
| Matthew Shields | TEVA | Ordinary Shares | Sale | -63.4% | $547,705 | $31.67 | -17,295 | 9,989 | 05 Mar 2026 | Direct |
| Matthew Shields | TEVA | Ordinary Shares | Options Exercise | 173.1% | 17,295 | 27,284 | 05 Mar 2026 | Direct | ||
| Matthew Shields | TEVA | Restricted Share Units | Options Exercise | -25% | -17,295 | 51,887 | 05 Mar 2026 | Direct | ||
| Richard D. Francis | TEVA | Ordinary Shares | Sale | -2% | $759,442 | $32.46 | -23,393 | 1,148,212 | 04 Mar 2026 | Direct |
| Richard D. Francis | TEVA | Ordinary Shares | Options Exercise | 4.48% | 50,223 | 1,171,605 | 04 Mar 2026 | Direct | ||
| Richard D. Francis | TEVA | Restricted Share Units | Award | 136,736 | 136,736 | 04 Mar 2026 | Direct | |||
| Richard D. Francis | TEVA | Restricted Share Units | Options Exercise | -33.3% | -50,223 | 100,446 | 04 Mar 2026 | Direct | ||
| Richard Daniell | TEVA | Ordinary Shares | Sale | -51.6% | $2,983,517 | $32.66 | -91,345 | 85,755 | 04 Mar 2026 | Direct |
| Richard Daniell | TEVA | Ordinary Shares | Options Exercise | 52.6% | 53,973 | 156,639 | 04 Mar 2026 | Direct | ||
| Richard Daniell | TEVA | Restricted Share Units | Award | 33,424 | 33,424 | 04 Mar 2026 | Direct | |||
| Richard Daniell | TEVA | Restricted Share Units | Options Exercise | -100% | -53,973 | 0 | 04 Mar 2026 | Direct | ||
| Placid Jover | TEVA | Restricted Share Units | Award | 37,982 | 37,982 | 04 Mar 2026 | Direct | |||
| Matthew Shields | TEVA | Restricted Share Units | Award | 33,424 | 33,424 | 04 Mar 2026 | Direct | |||
| Mark Sabag | TEVA | Ordinary Shares | Options Exercise | 23.8% | 52,113 | 271,319 | 04 Mar 2026 | Direct | ||
| Mark Sabag | TEVA | Restricted Share Units | Award | 30,385 | 30,385 | 04 Mar 2026 | Direct | |||
| Mark Sabag | TEVA | Restricted Share Units | Options Exercise | -100% | -52,113 | 0 | 04 Mar 2026 | Direct | ||
| Evan Lippman | TEVA | Restricted Share Units | Award | 27,347 | 27,347 | 04 Mar 2026 | Direct | |||
| Eric A. Hughes | TEVA | Ordinary Shares | Sale | -10.4% | $366,102 | $32.46 | -11,277 | 97,590 | 04 Mar 2026 | Direct |
| Eric A. Hughes | TEVA | Ordinary Shares | Options Exercise | 27.2% | 23,251 | 108,867 | 04 Mar 2026 | Direct | ||
| Eric A. Hughes | TEVA | Restricted Share Units | Award | 50,643 | 50,643 | 04 Mar 2026 | Direct | |||
| Eric A. Hughes | TEVA | Restricted Share Units | Options Exercise | -33.3% | -23,251 | 46,503 | 04 Mar 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.